KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) Invested Capital (2016 - 2026)

Medtronic (MDT) has disclosed Invested Capital for 14 consecutive years, with $49.4 billion as the latest value for Q1 2026.

  • Quarterly Invested Capital fell 5.46% to $49.4 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $49.4 billion through Jan 2026, down 5.46% year-over-year, with the annual reading at $51.1 billion for FY2025, 0.74% down from the prior year.
  • Invested Capital hit $49.4 billion in Q1 2026 for Medtronic, down from $50.3 billion in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $58.6 billion in Q3 2022 to a low of $49.4 billion in Q1 2026.
  • Historically, Invested Capital has averaged $53.0 billion across 5 years, with a median of $52.2 billion in 2025.
  • Biggest five-year swings in Invested Capital: grew 13.36% in 2022 and later decreased 11.42% in 2023.
  • Year by year, Invested Capital stood at $57.9 billion in 2022, then fell by 8.52% to $53.0 billion in 2023, then decreased by 1.04% to $52.4 billion in 2024, then fell by 4.12% to $50.3 billion in 2025, then dropped by 1.77% to $49.4 billion in 2026.
  • Business Quant data shows Invested Capital for MDT at $49.4 billion in Q1 2026, $50.3 billion in Q4 2025, and $50.6 billion in Q3 2025.